Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase (Q44605528)
Jump to navigation
Jump to search
scientific article published on December 1, 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase |
scientific article published on December 1, 2003 |
Statements
1 reference
Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase (English)
1 reference
1 reference
Z. Rudzki
A. Harper
A. Grigg
K. Taylor
S. Durrant
C. Arthur
P. Browett
A. P. Schwarer
D. Ma
J. F. Seymour
K. Bradstock
D. Joske
K. Lynch
I. Gathmann
1 December 2003
1 reference
1 reference
1 reference
17
1 reference
12
1 reference
2401-2409
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference